OSR Health (OSRHW) Asset Writedowns and Impairment (2024 - 2026)
OSR Health (OSRHW) posted Asset Writedowns and Impairment of $57.42 for Q1 2026, down 99.88% sequentially from $47891.0 in Q4 2025, and up 103.28% YoY from $28.25 in Q1 2025.
OSR Health (OSRHW) Asset Writedowns and Impairment (2024 - 2026) Analysis & Trends
OSR Health has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $57.42 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 103.28% year-over-year to $57.42 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44065.2 (changed N/A YoY) and the FY2025 annual result came in at $42257.0, down 26.77% from the prior year.
- Asset Writedowns and Impairment retreated to $57.42 in Q1 2026 per OSRHW's latest filing, from $47891.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $56360.0 in Q4 2024 and troughed at -$10658.2 in Q2 2025.
- A 3-year average of $14416.3 and a median of $2240.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2025 and 2026: Asset Writedowns and Impairment plunged 178.16% in 2025, then jumped 103.28% in 2026.
- Over 3 years, Asset Writedowns and Impairment stood at $56360.0 in 2024, then declined by 15.03% to $47891.0 in 2025, then plunged by 99.88% to $57.42 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $57.42, $47891.0, and $6775.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.42 |
| Mar 31, 2026 | 57.42 |
| Dec 31, 2025 | 47,891.00 |
| Dec 31, 2025 | 47,891.00 |
| Sep 30, 2025 | 6,775.00 |
| Sep 30, 2025 | 6,775.00 |
| Jun 30, 2025 | -10,658.20 |
| Jun 30, 2025 | -10,658.20 |
| Mar 31, 2025 | -1,750.80 |
| Mar 31, 2025 | -1,750.80 |
| Dec 31, 2024 | 56,360.00 |
| Dec 31, 2024 | 56,360.00 |
| Mar 31, 2024 | 2,240.00 |
| Mar 31, 2024 | 2,240.00 |